Vigilancia por el laboratorio de Streptococcus pneumoniae, aislado de procesos invasores en niños menores de 5 años: actualización de los datos 1994-2000

Agudelo, Clara Inés; Sanabria, Olga Marina; Ovalle, María Victoria; Castañeda, Elizabeth; Gallego, Carmen Rosa; Núñez, Sandra; Jaramillo, Edilma; Portilla, Vianey Emilce; Cano, Mercedes; Alvarez, María Helena; Murcia, Luz Mila; Sabogal, Constanza; Gartner, Martha; Hidalgo, Liliana; Uzeta, Martha.
Biomédica (Bogotá) ; 21(2): 193-199, jun. 2001. tab, graf
Artículo en Español | LILACS | ID: lil-315779

Documentos relacionados

  1. Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults.
  2. Pneumococcus and the stress-gradient hypothesis: A trade-off links R<sub>0</sub> and susceptibility to co-colonization across countries.
  3. High diversity within and low but significant genetic differentiation among geographic and temporal populations of the global <i>Streptococcus pneumoniae</i>.
  4. Streptococcus pneumoniae Serotypes Associated with Death, South Africa, 2012-2018.
  5. Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.
  6. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines.
  7. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
  8. Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation.
  9. Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study.
  10. A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus pneumoniae Serotype 2.